Guangdong Zhongsheng Pharmaceutical Co., Ltd.

XSEC:002317 Stock Report

Market Cap: CN¥11.0b

Guangdong Zhongsheng Pharmaceutical Future Growth

Future criteria checks 4/6

Guangdong Zhongsheng Pharmaceutical is forecast to grow earnings and revenue by 41.7% and 16.3% per annum respectively. EPS is expected to grow by 41.2% per annum. Return on equity is forecast to be 8.7% in 3 years.

Key information

41.7%

Earnings growth rate

41.2%

EPS growth rate

Pharmaceuticals earnings growth18.8%
Revenue growth rate16.3%
Future return on equity8.7%
Analyst coverage

Low

Last updated21 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSEC:002317 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,608431N/A3201
12/31/20253,121362N/A2921
12/31/20242,732244N/A1581
9/30/20242,447133219435N/A
6/30/20242,49314298340N/A
3/31/20242,505175-36257N/A
12/31/20232,611263-172191N/A
9/30/20232,756353-446-21N/A
6/30/20232,833328-447-37N/A
3/31/20232,747387-466-108N/A
1/1/20232,676322-20563N/A
9/30/20222,597213241441N/A
6/30/20222,545192411617N/A
3/31/20222,489295400598N/A
1/1/20222,429278409623N/A
9/30/20212,409-414-97100N/A
6/30/20212,321-330-15013N/A
3/31/20212,122-423-27126N/A
12/31/20201,896-427-16139N/A
9/30/20201,923251181323N/A
6/30/20202,010207189336N/A
3/31/20202,30724495240N/A
12/31/20192,532318123251N/A
9/30/20192,538454220356N/A
6/30/20192,474464320455N/A
3/31/20192,378439325449N/A
12/31/20182,362436183327N/A
9/30/20182,306455229381N/A
6/30/20182,197447N/A274N/A
3/31/20182,125432N/A192N/A
12/31/20171,964420N/A370N/A
9/30/20171,855427N/A223N/A
6/30/20171,837439N/A230N/A
3/31/20171,713432N/A297N/A
12/31/20161,692414N/A338N/A
9/30/20161,673380N/A274N/A
6/30/20161,640371N/A351N/A
3/31/20161,668325N/A334N/A
12/31/20151,578297N/A192N/A
9/30/20151,494276N/A356N/A
6/30/20151,433257N/A219N/A
3/31/20151,367238N/A75N/A
12/31/20141,309225N/A101N/A
9/30/20141,234219N/A96N/A
6/30/20141,190211N/A97N/A
3/31/20141,117194N/A144N/A
12/31/20131,090188N/A111N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 002317's forecast earnings growth (41.7% per year) is above the savings rate (2.8%).

Earnings vs Market: 002317's earnings (41.7% per year) are forecast to grow faster than the CN market (26.2% per year).

High Growth Earnings: 002317's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 002317's revenue (16.3% per year) is forecast to grow faster than the CN market (13.9% per year).

High Growth Revenue: 002317's revenue (16.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 002317's Return on Equity is forecast to be low in 3 years time (8.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y